-

US Treasury Department Moves Closer to Implementing Outbound Investment Restrictions Through Latest Proposed Regulations
On 21 June 2024, the Office of Investment Security of the US Department of the Treasury (Treasury) issued proposed regulations to implement President Biden’s August 2023 Executive Order on Addressing United States Investments in Certain National Security Technologies and Products in Countries of Concern (the EO) and certain proposals outlined in last year’s advance notice…
-

Don’t Forget About NFTs! USPTO and USCO Issue Joint Study on the Interplay Between NFTs and Intellectual Property
Non-fungible tokens (NFTs) have reshaped our socio-legal understanding of “property.” Prior to the launch of NFTs, laypersons and lawyers alike evaluated tangible and intangible assets in the context of physical (real) space. NFTs, however, have played a major role in shifting our valuation of assets beyond the physical realm, extending instead to the recognition of…
-

Another Leak Confirmed and Other Important Decisions and Divisions Issued, but Not Loper or Trump – SCOTUS Today
The Supreme Court’s day started with the specter of yet another leak of a reproductive rights decision having occurred….By: Epstein Becker & Green
-

Client Alert: IARC to Evaluate Automotive Gasoline and Oxygenated Additives in Early 2025
Earlier this year, the International Agency for Research on Cancer (IARC) announced that it will be evaluating “automotive gasoline and some oxygenated additives” between February and March 2025. IARC Monographs – Volume 138 – IARC Monographs on the Identification of Carcinogenic Hazards to Humans (who.int). The additives to be evaluated include MTBE, ETBE, DIPE, and…
-

Broad Biotech Patent Claims-the Saga Continues
There now is increased interest about the written description and enablement requirements for patent applications claiming antibodies. This may stem from the recent U.S. Supreme Court decision in Amgen v. Sanofi, finding lack of enablement for broad antibody claims….By: Lathrop GPM
-

Federal District Court Denied Spoliation Motion Where Plaintiffs Attempted to Argue that a Bus Company Failed to Preserve Video
Williams v. First Student, Inc., 2024 WL 1132237, No. 20-cv-1176 (CPO) (SAK) (D. N.J. Mar. 15, 2024) – The plaintiffs’ sought to obtain a preclusion of expert evidence and adverse inference at trial for failure to maintain video after an infant plaintiff disembarked one school bus and was struck by another company’s school bus, causing…
-

Southern District of New York Judge Rules that Plaintiff Failed to Meet the Serious Injury Threshold
Vadnais v. United States of America, 2024 WL 1101823, No. 21-cv-0012 (KHP) (S.D.N.Y. Mar. 13, 2024) – This matter may be a perfect example of the strategic benefit of litigating in federal court as opposed to New York State courts whenever possible. This case involved a classic type of he said/she said scenario, which revolved…
-

Ohio Appeals Court Affirms Dismissal of Complaint by the Estate of Decedent Who Intentionally Created Accidents with Tractor Trailers
Estate of Coumbassa v. Hickle, 2023 WL 8234445, 2023-Ohio-4292 (Ohio App. Nov. 28, 2023) – A fantastic set of facts saw a lower court’s ruling affirmed by the appellate court when a motorist/decedent, whose actions were interpreted as “intentional” and could ultimately have been suicidal, created two collisions with tractor trailers while traveling eastbound on…
-

Product Importers: Are You Ready for the New PFAS Reporting Requirements Under TSCA?
The U.S. Environmental Protection Agency (EPA) published a far-reaching and important final rule (Rule) on Oct. 11, 2023, requiring comprehensive reporting of per- and polyfluoroalkyl substances (PFAS) manufactured and imported in the U.S. under the Toxic Substances Control Act (TSCA). For background on the Rule, see Holland & Knight’s previous alert, “EPA Publishes Comprehensive PFAS……By:…
-

Peer Review Can’t Save “Junk Science” from FRE 702 Judicial Gatekeeping – In re: Roundup Court Excludes Expert Whose Opinions Had Been Published in Peer-Reviewed Literature
When tasked with assessing the admissibility of expert testimony under Federal Rule of Evidence 702, courts often cite the so-called Daubert factors as criteria that guide the inquiry. Among those factors is “whether the [expert’s] theory or technique has been subjected to peer review and publication.” Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579…